Moreover, PDK4 was also decreased in multiple carcinomas as previously described, such as prostate carcinoma, breast carcinoma, lung carcinoma, and liver carcinoma (Grassian et al., 2011; Mengual et al., 2014; Sun et al., 2014; Choiniere et al., 2017). Here, PDK4 is linked to breast carcinoma.